Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Encouraging Side

Well, based on the volume between yesterday and today, it's apparent nobody other than current investors are paying much attention to PTSC. Or if they are, they won't believe any PR's that aren't backed up by actual positive results.

With that in mind, IF there is success in the efforts described in the PR issued AND PTSC can get that publicized, there is the opportunity that interest can be generated from new investors. I think that succes will need to include clear information about increased license fees to PDS and NET PROFIT to PTSC, and / or the leverage that injunctive relief would represent if the ITC were to go that route.

The good thing is there's an opportunity in the 10-K to be issued in a couple of weeks, for PTSC to show if the Disney & Ford licenses brought in substantially higher fees, and for them to include in the subsequent events section any significant activity that might have happened since May 31.

Opportunities to tell a story and to get it out are there. The question is, is there a story to tell? Let's hope so. Right now, no one believes it, or at least no one is paying attention to it.

Share
New Message
Please login to post a reply